SYNERGY PHARMACEUTICALS, INC. 4

4 · SYNERGY PHARMACEUTICALS, INC. · Filed May 1, 2017

Insider Transaction Report

Form 4
Period: 2017-05-01
Gemignani Gary G
Executive Vice Pres. & CFO
Transactions
  • Award

    Stock Options

    2017-05-01+375,000375,000 total
    Exercise: $4.12Exp: 2027-05-01Common Stock (375,000 underlying)
Footnotes (1)
  • [F1]125,000 of the stock options vest on each of 4/17/2018, 2019 and 2020.

Documents

1 file
  • 4
    a4.xmlPrimary

    4